Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in Lowering the Risk of HCC Development in Patients With CHB. - Kang SH; Yim HJ; Han SK; Yim SY; Kim TH; Lee YS; Shin SK; Jung YK; Kim MY; Kim JH; Seo YS; Kwon OS; et al. (Journal of gastroenterology and hepatology, 2026)